Epigenetic modifications are essential regulators of biological processes. Decreased DNA methylation of OAS2 (2'-5'-Oligoadenylate Synthetase 2), encoding an antiviral protein, has been seen in psoriasis. To provide further insight into the epigenetic regulation of OAS2, we performed pyrosequencing to detect OAS2 DNA methylation status at 11 promoter and first exon located CpG sites in psoriasis (n = 12) and two common subtypes of squamous cell carcinoma (SCC) of the head and neck: tongue (n = 12) and tonsillar (n = 11). Compared to corresponding controls, a general hypomethylation was seen in psoriasis. In tongue and tonsillar SCC, hypomethylation was found at only two CpG sites, the same two sites that were least demethylated in psoriasis. Despite differences in the specific residues targeted for methylation/demethylation, OAS2 expression was upregulated in all conditions and correlations between methylation and expression were seen in psoriasis and tongue SCC. Distinctive methylation status at four successively located CpG sites within a genomic area of 63 bp reveals a delicately integrated epigenetic program and indicates that detailed analysis of individual CpGs provides additional information into the mechanisms of epigenetic regulation in specific disease states. Methylation analyses as clinical biomarkers need to be tailored according to disease-specific sites.

Department of Clinical Sciences ENT Umeå University Umeå Sweden

Department of Medical Biosciences Pathology Umeå University Umeå Sweden

Department of Public Health and Clinical Medicine Dermatology and Venereology Umeå University Umeå Sweden

Institut de Génétique Moléculaire Université Paris 7 Hôpital St Louis Paris France

RECAMO Masaryk Memorial Cancer Institute Brno Czech Republic

Zobrazit více v PubMed

Ziller M. J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477–481 (2013). PubMed PMC

Smith Z. D. & Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204–220 (2013). PubMed

Jones P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492 (2012). PubMed

Plongthongkum N., Diep D. H. & Zhang K. Advances in the profiling of DNA modifications: cytosine methylation and beyond. Nat. Rev. Genet. 15, 647–661 (2014). PubMed

Schubeler D. Function and information content of DNA methylation. Nature 517, 321–326 (2015). PubMed

Bock C. Analysing and interpreting DNA methylation data. Nat. Rev. Genet. 13, 705–719 (2012). PubMed

Choi U. Y., Kang J. S., Hwang Y. S. & Kim Y. J. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 47, e144 (2015). PubMed PMC

Dar A. A. et al. Extracellular 2′5′-oligoadenylate synthetase 2 mediates T-cell receptor CD3-zeta chain down-regulation via caspase-3 activation in oral cancer. Immunology 147, 251–264 (2016). PubMed PMC

Mozzi A. et al. OASes and STING: adaptive evolution in concert. Genome Biol. Evol. 7, 1016–1032 (2015). PubMed PMC

Dan M., Zheng D., Field L. L. & Bonnevie-Nielsen V. Induction and activation of antiviral enzyme 2′,5′-oligoadenylate synthetase by in vitro transcribed insulin mRNA and other cellular RNAs. Mol. Biol. Rep. 39, 7813–7822 (2012). PubMed

Dugan J. W. et al. Nucleotide oligomerization domain-2 interacts with 2′-5′-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. Mol. immunol. 47, 560–566 (2009). PubMed PMC

Perera G. K., Di Meglio P. & Nestle F. O. Psoriasis. Annu. rev. pathol. 7, 385–422 (2012). PubMed

Keermann M. et al. Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genomics 16, 322 (2015). PubMed PMC

Roberson E. D. et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. J. Invest. Dermatol. 132, 583–592 (2012). PubMed PMC

Kamangar F., Dores G. M. & Anderson W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137–2150 (2006). PubMed

Pezzuto F. et al. Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology 89, 125–136 (2015). PubMed

Gupta K. & Metgud R. Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Pathol. Res. Int. 2013, 642496 (2013). PubMed PMC

Abogunrin S., Di Tanna G. L., Keeping S., Carroll S. & Iheanacho I. Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. BMC Cancer 14, 968 (2014). PubMed PMC

Loizou C. et al. Incidence of tonsillar cancer in northern Sweden: impact of human papilloma virus. Oncol. Lett. (2015). PubMed PMC

Sgaramella N. et al. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br. J. Cancer 113, 321–326 (2015). PubMed PMC

Colella S., Shen L., Baggerly K. A., Issa J. P. & Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. BioTechniques 35, 146–150 (2003). PubMed

Hoffmann M. et al. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Cancer Lett. 323, 88–96 (2012). PubMed

Detre S., Saclani Jotti G. & Dowsett M. A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J. Clin. Pathol. 48, 876–878 (1995). PubMed PMC

Gu X., Nylander E., Coates P. J., Fahraeus R. & Nylander K. Correlation between Reversal of DNA Methylation and Clinical Symptoms in Psoriatic Epidermis Following Narrow-Band UVB Phototherapy. J. Invest. Dermatol. 135, 2077–2083 (2015). PubMed PMC

Gu X., Nylander E., Coates P. J. & Nylander K. Oxidation reduction is a key process for successful treatment of psoriasis by narrow-band UVB phototherapy. Acta Derm.-Venereol. 95, 140–146 (2015). PubMed

Roadmap Epigenomics C. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015). PubMed PMC

Karolchik D. et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32, D493–D496 (2004). PubMed PMC

Lokk K. et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome biol. 15, r54 (2014). PubMed PMC

Bibikova M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288–295 (2011). PubMed

Peters T. J. et al. De novo identification of differentially methylated regions in the human genome. Epigenet. Chromatin 8, 6 (2015). PubMed PMC

Claus R. et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J. Clin. Oncol. 30, 2483–2491 (2012). PubMed PMC

Nusgen N. et al. Inter-locus as well as intra-locus heterogeneity in LINE-1 promoter methylation in common human cancers suggests selective demethylation pressure at specific CpGs. Clin. epigenet. 7, 17 (2015). PubMed PMC

Gutierrez-Arcelus M. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Life 2, e00523 (2013). PubMed PMC

Marchal C. & Miotto B. Emerging concept in DNA methylation: role of transcription factors in shaping DNA methylation patterns. J. Cell. Physiol. 230, 743–751 (2015). PubMed

Hovanessian A. G. & Justesen J. The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie 89, 779–788 (2007). PubMed

Heyn H. & Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genet. 13, 679–692 (2012). PubMed

Mikeska T. & Craig J. M. DNA methylation biomarkers: cancer and beyond. Genes (Basel) 5, 821–864 (2014). PubMed PMC

High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue

AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck

Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC